KPCB XII Associates
Latest statistics and disclosures from KPCB XII Associates's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Amyris, and represent 100.00% of KPCB XII Associates's stock portfolio.
- Reduced shares in these 1 stock: INSP (-$35M).
- Sold out of its position in INSP.
- KPCB XII Associates was a net seller of stock by $-35M.
- KPCB XII Associates has $738k in assets under management (AUM), dropping by -97.93%.
- Central Index Key (CIK): 0001500599
Tip: Access up to 7 years of quarterly data
Positions held by KPCB XII Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for KPCB XII Associates
KPCB XII Associates holds 1 positions in its portfolio as reported in the September 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Amyris Common Stock | 100.0 | $738k | 253k | 2.92 |
|
Past Filings by KPCB XII Associates
SEC 13F filings are viewable for KPCB XII Associates going back to 2018
- KPCB XII Associates 2020 Q3 filed Oct. 20, 2020
- KPCB XII Associates 2020 Q2 filed Aug. 3, 2020
- KPCB XII Associates 2020 Q1 filed April 10, 2020
- KPCB XII Associates 2019 Q4 filed Feb. 13, 2020
- KPCB XII Associates 2019 Q3 filed Nov. 13, 2019
- KPCB XII Associates 2019 Q2 filed Aug. 7, 2019
- KPCB XII Associates 2019 Q1 filed April 25, 2019
- KPCB XII Associates 2018 Q4 filed Feb. 14, 2019